159 related articles for article (PubMed ID: 28844518)
41. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy.
Zoungas S; Ninomiya T; Huxley R; Cass A; Jardine M; Gallagher M; Patel A; Vasheghani-Farahani A; Sadigh G; Perkovic V
Ann Intern Med; 2009 Nov; 151(9):631-8. PubMed ID: 19884624
[TBL] [Abstract][Full Text] [Related]
42. Prevention of contrast induced nephropathy with sodium bicarbonate (the PROMEC study).
Nieto-Ríos JF; Salazar WA; Sánchez OM; Ortega JL; Caro JI; Aristizabal JM; Higuita LM; García ÁG; Barragán FA
J Bras Nefrol; 2014; 36(3):360-6. PubMed ID: 25317619
[TBL] [Abstract][Full Text] [Related]
43. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
Maioli M; Toso A; Leoncini M; Micheletti C; Bellandi F
Circ Cardiovasc Interv; 2011 Oct; 4(5):456-62. PubMed ID: 21972403
[TBL] [Abstract][Full Text] [Related]
44. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.
Ebisawa S; Kurita T; Tanaka N; Nasu K; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Terashima M; Suzuki T
Cardiovasc Interv Ther; 2016 Jan; 31(1):13-20. PubMed ID: 26001976
[TBL] [Abstract][Full Text] [Related]
45. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
[TBL] [Abstract][Full Text] [Related]
46. N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Staniloae CS; Doucet S; Sharma SK; Katholi RE; Mody KR; Coppola JT; Solomon R
J Interv Cardiol; 2009 Jun; 22(3):261-5. PubMed ID: 19490358
[TBL] [Abstract][Full Text] [Related]
47. Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention.
Yang K; Liu W; Ren W; Lv S
Int Urol Nephrol; 2014 Sep; 46(9):1801-7. PubMed ID: 24966097
[TBL] [Abstract][Full Text] [Related]
48. Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures.
Ueda H; Yamada T; Masuda M; Okuyama Y; Morita T; Furukawa Y; Koji T; Iwasaki Y; Okada T; Kawasaki M; Kuramoto Y; Naito T; Fujimoto T; Komuro I; Fukunami M
Am J Cardiol; 2011 Apr; 107(8):1163-7. PubMed ID: 21349483
[TBL] [Abstract][Full Text] [Related]
49. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Qian G; Fu Z; Guo J; Cao F; Chen Y
JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
[TBL] [Abstract][Full Text] [Related]
50. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial.
Habib M; Hillis A; Hammad A
Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):55-61. PubMed ID: 26787567
[TBL] [Abstract][Full Text] [Related]
51. Comparison of effects of isotonic sodium chloride with diltiazem in prevention of contrast-induced nephropathy.
Beyazal H; Caliskan Z; Utaç C
Ren Fail; 2014 Apr; 36(3):351-5. PubMed ID: 24341598
[TBL] [Abstract][Full Text] [Related]
52. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
53. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials.
Trivedi H; Nadella R; Szabo A
Clin Nephrol; 2010 Oct; 74(4):288-96. PubMed ID: 20875381
[TBL] [Abstract][Full Text] [Related]
54. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T
Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141
[TBL] [Abstract][Full Text] [Related]
55. Na/K citrate versus sodium bicarbonate in prevention of contrast-induced nephropathy.
Abouzeid SM; ElHossary HE
Saudi J Kidney Dis Transpl; 2016 May; 27(3):519-25. PubMed ID: 27215244
[TBL] [Abstract][Full Text] [Related]
56. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy.
Liu Y; Chen JY; Tan N; Zhou YL; Yu DQ; Chen ZJ; He YT; Liu YH; Luo JF; Huang WH; Li G; He PC; Yang JQ; Xie NJ; Liu XQ; Yang DH; Huang SJ; Piao-Ye ; Li HL; Ran P; Duan CY; Chen PY
Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26041500
[TBL] [Abstract][Full Text] [Related]
57. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
[TBL] [Abstract][Full Text] [Related]
58. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease.
Rosenstock JL; Gilles E; Geller AB; Panagopoulos G; Mathew S; Malieckal D; DeVita MV; Michelis MF
Int Urol Nephrol; 2010 Dec; 42(4):1049-54. PubMed ID: 20602168
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
60. Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
Duan N; Zhao J; Li Z; Dong P; Wang S; Zhao Y; Wang L; Wang H
Med Sci Monit; 2015 Jan; 21():292-7. PubMed ID: 25613017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
